Background Interstitial lung disease (ILD) is characterised by reduced functional capacity,
dyspnoea and exercise‐induced hypoxia. Pulmonary rehabilitation is often used to improve …

ABSTRACT Introduction: Coronavirus disease 2019 (COVID-19) is still increasing
worldwide, and as a result, the number of patients with pulmonary fibrosis secondary to …

Background Uncertainty exists regarding the clinical relevance of exercise training across
the range of interstitial lung diseases (ILDs). Objective To establish the impact of exercise …

Objectives: To identify exercise tests that are suitable for home-based or remote
administration in people with chronic lung disease. Methods: Rapid review of studies that …

The battle against COVID-19 has entered a new phase with Rehabilitation Centres being
among the major players, because the medical outcome of COVID-19 patients does not end …

Despite the development of pharmacological therapies that are effective in slowing the
progression of idiopathic pulmonary fibrosis (IPF), it remains a debilitating and lethal …

Background Few data are available on the long-term effect of pulmonary rehabilitation (PR)
and on long PR programs in interstitial lung diseases (ILD). We aimed to evaluate the effects …

Background Idiopathic pulmonary fibrosis (IPF) is a progressive disease associated with
significant dyspnea and limited exercise capacity. This systematic review aimed to …

Introduction The 16-week randomised, placebo-controlled INCREASE trial (RCT) met its
primary end-point by improving 6-min walk distance (6MWD) in patients receiving inhaled …

Idiopathic pulmonary fibrosis (IPF), a chronic and progressive fibrosing interstitial
pneumonia, is a fatal lung disease with a median survival time of 3–5 years. Problems in …